| mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.9 |
| mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.9 |
| mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.9 |
| mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |